MoneyWorks4Me

Glenmark Pharmaceuticals board to consider financial statements

19 Oct 2012 Evaluate
Glenmark Pharmaceuticals has informed that a meeting of the board of directors will be held on October 30, 2012, to consider and approve the company’s un-audited financial statements for the second quarter/half year ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..